Despite evidence that the flu hurts seniors, digital “nudges” like texts or emails aren’t really enough to move the needle on vaccine rates.
Employer COVID-19 vaccine mandates significantly increase uptake with little effect on staffing: study
By
Kimberly Bonvissuto
Aug 08, 2023
An employee mandate led to a “significant” increase in COVID-19 vaccine uptake with little effect on staffing in a multi-state network of continuing care retirement communities studied by researchers,...
FDA authorizes spring COVID-19 booster for certain Americans
Apr 18, 2023
Seniors aged 65 years and older can get a booster at least four months following their first dose of the bivalent vaccine.
COVID-19 deaths preventable if available tools used: expert
By
Kimberly Bonvissuto
Jan 10, 2023
Most deaths attributable to COVID-19 today are preventable through the use of tools including vaccines, quality face masks and antiviral treatments, according to a special pathogens expert.
Single dose of RSV vaccine prevents acute respiratory infection in seniors
Feb 17, 2023
High vaccine efficacy was seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions.
Bivalent COVID-19 mRNA booster effective
Dec 21, 2022
The bivalent booster is effective against COVID-19 hospitalization in immunocompetent adults and seniors.
White House urges COVID-19 booster shots again, citing effectiveness
Nov 23, 2022
The booster vaccine adds between 30 and 56% more protection against getting COVID-19.
CDC panel gives support to new COVID-19 booster shots
Sep 13, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Bill would expand provider National Practitioner Data Bank access to long-term care providers
By
Kathleen Steele Gaivin
Jul 24, 2023
Legislation re-introduced last week by Sens. Marco Rubio (R-FL) and Jacky Rosen (D-NV) would expand access to the National Practitioner Data Bank to include long-term care providers such as nursing homes...
FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.